NO128068B - - Google Patents
Download PDFInfo
- Publication number
- NO128068B NO128068B NO00613/69A NO61369A NO128068B NO 128068 B NO128068 B NO 128068B NO 00613/69 A NO00613/69 A NO 00613/69A NO 61369 A NO61369 A NO 61369A NO 128068 B NO128068 B NO 128068B
- Authority
- NO
- Norway
- Prior art keywords
- sulfamyl
- indoline
- chloro
- methyl
- parts
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 6
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 claims description 5
- 230000001882 diuretic effect Effects 0.000 claims description 4
- YELHZVMLYJGTFN-UHFFFAOYSA-N 2-methyl-2,3-dihydroindol-1-amine Chemical compound C1=CC=C2N(N)C(C)CC2=C1 YELHZVMLYJGTFN-UHFFFAOYSA-N 0.000 claims description 3
- SCYSJFKWFQZRJW-UHFFFAOYSA-N 4-chloro-3-sulfamoylbenzoyl chloride Chemical compound NS(=O)(=O)C1=CC(C(Cl)=O)=CC=C1Cl SCYSJFKWFQZRJW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WLFGGJFWKXTOGJ-UHFFFAOYSA-N 2,3-dihydroindol-1-amine Chemical compound C1=CC=C2N(N)CCC2=C1 WLFGGJFWKXTOGJ-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- -1 lithium aluminum hydride Chemical compound 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009935 nitrosation Effects 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000054 salidiuretic effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB00906/68A GB1203691A (en) | 1968-03-06 | 1968-03-06 | New disubstituted n-amino indoline derivatives and process for preparing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO128068B true NO128068B (cg-RX-API-DMAC7.html) | 1973-09-24 |
Family
ID=9976474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00613/69A NO128068B (cg-RX-API-DMAC7.html) | 1968-03-06 | 1969-02-14 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3565911A (cg-RX-API-DMAC7.html) |
| BE (1) | BE728658A (cg-RX-API-DMAC7.html) |
| CH (1) | CH507940A (cg-RX-API-DMAC7.html) |
| DE (1) | DE1909180A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK126193B (cg-RX-API-DMAC7.html) |
| ES (1) | ES364421A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI50119C (cg-RX-API-DMAC7.html) |
| FR (1) | FR2003311A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1203691A (cg-RX-API-DMAC7.html) |
| IT (1) | IT8049196A0 (cg-RX-API-DMAC7.html) |
| NL (1) | NL145226B (cg-RX-API-DMAC7.html) |
| NO (1) | NO128068B (cg-RX-API-DMAC7.html) |
| SE (1) | SE334887B (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4112111A (en) * | 1975-02-26 | 1978-09-05 | Sandoz Ltd. | Indolinylguanidines |
| IT1113879B (it) * | 1979-03-15 | 1986-01-27 | Farmatis Spa | Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo |
| LU82949A1 (fr) * | 1980-11-20 | 1981-06-04 | Usv Pharma Corp | Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension |
| ATE15659T1 (de) * | 1980-12-22 | 1985-10-15 | Usv Pharma Corp | Synthese von indolinen. |
| JPS57206657A (en) * | 1981-06-16 | 1982-12-18 | Mitsui Toatsu Chem Inc | Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component |
| FR2529785A1 (fr) * | 1982-07-09 | 1984-01-13 | Adir | Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne |
| FR2663325B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique. |
| FR2663324B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide. |
| FR2677886B1 (fr) * | 1991-06-18 | 1995-03-31 | Adir | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. |
| US5319096A (en) * | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
| IT1288123B1 (it) * | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
| EA200500234A1 (ru) | 2002-08-19 | 2005-08-25 | Пфайзер Продактс Инк. | Комбинированная терапия гиперпролиферативных болезней |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| US20080275093A1 (en) * | 2004-11-15 | 2008-11-06 | Nitromed, Inc. | Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| FR2924713B1 (fr) * | 2007-12-11 | 2010-01-29 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2011149438A1 (en) | 2010-05-28 | 2011-12-01 | Mahmut Bilgic | Combination of antihypertensive agents |
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
| KR20220170360A (ko) * | 2021-06-21 | 2022-12-29 | 에이에스엠 아이피 홀딩 비.브이. | 인듐 갈륨 아연 산화물을 포함한 층을 형성하기 위한 반응기 시스템 및 방법 |
| EP4373474A1 (en) | 2021-07-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Bilayer tablet comprising telmisartan and indapamide |
| EP4295839A1 (en) | 2022-06-20 | 2023-12-27 | KRKA, d.d., Novo mesto | Combination of valsartan and indapamide |
| EP4374855A1 (en) | 2022-11-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Pharmaceutical dosage form of candesartan and indapamide |
| SI4559899T1 (sl) | 2023-11-21 | 2026-06-30 | Krka, D.D., Novo Mesto | Sinteza 1-amino-2-metil-2,3-dihidroindola z nitroziranjem 2-metil-2,3-dihidro-1h-indola in naknadno redukcijo dobljenega 1-nitrozo-2-metil-2,3-dihidroindola s tiourea dioksidom |
-
1968
- 1968-03-06 GB GB00906/68A patent/GB1203691A/en not_active Expired
-
1969
- 1969-02-14 NO NO00613/69A patent/NO128068B/no unknown
- 1969-02-19 BE BE728658D patent/BE728658A/xx not_active IP Right Cessation
- 1969-02-24 DE DE19691909180 patent/DE1909180A1/de active Pending
- 1969-02-25 US US802208A patent/US3565911A/en not_active Expired - Lifetime
- 1969-02-26 DK DK106769AA patent/DK126193B/da unknown
- 1969-03-03 SE SE02903/69A patent/SE334887B/xx unknown
- 1969-03-05 FR FR6906023A patent/FR2003311A1/fr active Pending
- 1969-03-05 CH CH334269A patent/CH507940A/fr not_active IP Right Cessation
- 1969-03-05 ES ES364421A patent/ES364421A1/es not_active Expired
- 1969-03-05 FI FI690659A patent/FI50119C/fi active
- 1969-03-05 NL NL696903421A patent/NL145226B/xx not_active IP Right Cessation
-
1980
- 1980-07-09 IT IT8049196A patent/IT8049196A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6903421A (cg-RX-API-DMAC7.html) | 1969-09-09 |
| DK126193B (da) | 1973-06-18 |
| FI50119C (fi) | 1975-12-10 |
| ES364421A1 (es) | 1971-02-01 |
| FR2003311A1 (cg-RX-API-DMAC7.html) | 1969-11-07 |
| NL145226B (nl) | 1975-03-17 |
| BE728658A (cg-RX-API-DMAC7.html) | 1969-08-19 |
| CH507940A (fr) | 1971-05-31 |
| FI50119B (cg-RX-API-DMAC7.html) | 1975-09-01 |
| DE1909180A1 (de) | 1970-07-02 |
| US3565911A (en) | 1971-02-23 |
| IT8049196A0 (it) | 1980-07-09 |
| GB1203691A (en) | 1970-09-03 |
| SE334887B (cg-RX-API-DMAC7.html) | 1971-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7372957B2 (ja) | アミノピリミジンｓｓａｏ阻害剤 | |
| FI88504C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat | |
| US3565911A (en) | Disubstituted n-amino indoline compounds | |
| CA2694724C (en) | Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer | |
| NO132733B (cg-RX-API-DMAC7.html) | ||
| NO146541B (no) | Fremgangsmaate for fremstilling av myke etyleniske polymerharpiksskum | |
| NO128569B (cg-RX-API-DMAC7.html) | ||
| NO121783B (cg-RX-API-DMAC7.html) | ||
| SK286471B6 (sk) | Deriváty 2-fenylpyran-4-ónu, spôsob ich prípravy,farmaceutické kompozície s ich obsahom a ich použitie | |
| NO120758B (cg-RX-API-DMAC7.html) | ||
| NO128157B (cg-RX-API-DMAC7.html) | ||
| NO143459B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive 2-fenylimino-imidazolidin-derivater | |
| NO163597B (no) | Styreinnretning for et ett-eller tosporet kjoeretoey. | |
| Potts et al. | Mesoionic compounds. XIV. Mesoionic compounds of the imidazole series | |
| JPH0351704B2 (cg-RX-API-DMAC7.html) | ||
| NO158677B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater. | |
| Remy et al. | (+)-and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine | |
| GOLUMBIC et al. | CHEMICAL REACTIONS OF THE NITROGEN MUSTARD GASES. 1 II. THE COMPOSITION OF AGED UNBUFFERED SOLUTIONS OF METHYL-BIS (β-CHLOROETHYL) AMINE | |
| NO145651B (no) | Maskin for stoeping av betongroer i staaende stilling. | |
| US4124604A (en) | Bis-[(5-p-chlorophenyl)furfuryl]amine hydrochloride | |
| Robertson et al. | Rearrangements of dehydroproline derivatives | |
| US3278541A (en) | Di-substituted-n-alkyl piperidines | |
| NO761537L (cg-RX-API-DMAC7.html) | ||
| CA1094553A (en) | 1-amino substituted indoline derivatives as vasoconstricting agents | |
| NO139050B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater |